The molecular landscape of head and neck cancer

[1]  G. Mills,et al.  Reverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancer. , 2014, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  Petar Stojanov,et al.  Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas , 2014, Clinical Cancer Research.

[3]  Shao Hui Huang,et al.  Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. , 2016, The Lancet. Oncology.

[4]  Francisco J. Sánchez-Rivera,et al.  Keap1 loss promotes Kras-driven lung cancer and results in a dependence on glutaminolysis , 2017, Nature Medicine.

[5]  Steven A. Roberts,et al.  An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers , 2013, Nature Genetics.

[6]  C. R. Leemans,et al.  Multiple head and neck tumors frequently originate from a single preneoplastic lesion. , 2002, The American journal of pathology.

[7]  D. Busam,et al.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.

[8]  Adam A. Margolin,et al.  Functional Kinomics Identifies Candidate Therapeutic Targets in Head and Neck Cancer , 2014, Clinical Cancer Research.

[9]  Maureen A. Sartor,et al.  Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures , 2016, Clinical Cancer Research.

[10]  Kevin P. White,et al.  Integrative Analysis of Head and Neck Cancer Identifies Two Biologically Distinct HPV and Three Non-HPV Subtypes , 2014, Clinical Cancer Research.

[11]  G. Collins.  The next generation. , 2006, Scientific American.

[12]  Susan A. Cole,et al.  Field , 2018, The Body Wars.

[13]  Christopher R. Cabanski,et al.  Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types , 2010, Clinical Cancer Research.

[14]  S. Sanjosé,et al.  HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. , 2014, The Lancet. Oncology.

[15]  M. Rietbergen,et al.  Molecular characterization of p16‐immunopositive but HPV DNA‐negative oropharyngeal carcinomas , 2014, International journal of cancer.

[16]  C. Eaves,et al.  Characterization of Epithelial Progenitors in Normal Human Palatine Tonsils and Their HPV16 E6/E7-Induced Perturbation , 2015, Stem cell reports.

[17]  R. Gregory,et al.  MicroRNA biogenesis pathways in cancer , 2015, Nature Reviews Cancer.

[18]  A. Giuliano,et al.  Oral Human Papillomavirus in Healthy Individuals: A Systematic Review of the Literature , 2010, Sexually transmitted diseases.

[19]  M. Takeichi,et al.  Mammalian Fat1 cadherin regulates actin dynamics and cell–cell contact , 2004, The Journal of cell biology.

[20]  M. Scholz,et al.  The role of HPV RNA transcription, immune response‐related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer , 2015, International journal of cancer.

[21]  D. Sidransky,et al.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.

[22]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[23]  S. Stoeckli,et al.  Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer. , 2015, European journal of cancer.

[24]  I. van der Waal,et al.  Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. , 2009, Oral oncology.

[25]  C. Meijer,et al.  PIK3CA-mediated PI3-kinase signalling is essential for HPV-induced transformation in vitro , 2011, Molecular Cancer.

[26]  C. R. Leemans,et al.  Expression signature in peripheral blood cells for molecular diagnosis of head and neck squamous cell carcinoma. , 2013, Oral diseases.

[27]  Li Zhao,et al.  Oncogenic PI3K deregulates transcription and translation , 2005, Nature Reviews Cancer.

[28]  M. Pawlita,et al.  Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement. , 2012, Cancer research.

[29]  C. R. Leemans,et al.  Genetically Altered Fields as Origin of Locally Recurrent Head and Neck Cancer , 2004, Clinical Cancer Research.

[30]  C. R. Leemans,et al.  A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen , 2007, International journal of cancer.

[31]  H. Marie,et al.  Ajuba, a cytosolic LIM protein, shuttles into the nucleus and affects embryonal cell proliferation and fate decisions. , 2000, Molecular biology of the cell.

[32]  C. Meijer,et al.  Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions , 2014, Nature Reviews Cancer.

[33]  David L. Masica,et al.  Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[34]  Hans Clevers,et al.  Notch1 functions as a tumor suppressor in mouse skin , 2003, Nature Genetics.

[35]  J. Califano,et al.  11:40 AM: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization , 1996 .

[36]  C. R. Leemans,et al.  Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma , 2011, International Journal of Cancer.

[37]  Geoffrey Childs,et al.  Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays , 2001, Nature Genetics.

[38]  J. Lukas,et al.  Replication Catastrophe: When a Checkpoint Fails because of Exhaustion. , 2017, Molecular cell.

[39]  Activation of the NOTCH pathway in head and neck cancer. , 2014, Cancer research.

[40]  A. Sparks,et al.  The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.

[41]  A. Hui,et al.  Tumor‐derived exosomes and microvesicles in head and neck cancer: Implications for tumor biology and biomarker discovery , 2013, Proteomics.

[42]  M. von Knebel Doeberitz,et al.  Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta‐analysis , 2017, International journal of cancer.

[43]  H. Saya,et al.  Aurora-A and an Interacting Activator, the LIM Protein Ajuba, Are Required for Mitotic Commitment in Human Cells , 2003, Cell.

[44]  I. Weissman,et al.  Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.

[45]  Hanlee P. Ji,et al.  Pan-cancer analysis of the extent and consequences of intratumor heterogeneity , 2015, Nature Medicine.

[46]  I. Mackenzie,et al.  Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative. , 2011, Cancer research.

[47]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[48]  M. Nicolau,et al.  Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data , 2015, Oncotarget.

[49]  R. Brakenhoff,et al.  Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways , 2011, International journal of cancer.

[50]  D. Brachman,et al.  Molecular biology of head and neck cancer. , 1994, Seminars in oncology.

[51]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[52]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[53]  S. Franceschi,et al.  Prevalence of human papillomavirus in tonsil brushings and gargles in cancer-free patients: The SPLIT study. , 2017, Oral oncology.

[54]  S. Schnitt,et al.  Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy , 2010, Modern Pathology.

[55]  Carole Fakhry,et al.  Case-control study of human papillomavirus and oropharyngeal cancer. , 2007, The New England journal of medicine.

[56]  E. Choi,et al.  HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c‐myc during tumor formation , 2007, International journal of cancer.

[57]  D. Slaughter,et al.  “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin , 1953, Cancer.

[58]  C. Perou,et al.  Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. , 2004, Cancer cell.

[59]  T. Dreyer,et al.  Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma , 2002, The Journal of pathology.

[60]  J. Lunceford,et al.  Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial. , 2016, The Lancet. Oncology.

[61]  R. Gibbs,et al.  Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1 , 2011, Science.

[62]  K. Harrington,et al.  Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. , 2016, The New England journal of medicine.

[63]  D. Hayes,et al.  Genetic Landscape of Human Papillomavirus-Associated Head and Neck Cancer and Comparison to Tobacco-Related Tumors. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[64]  M. Kulesz-Martin,et al.  Overexpression of PIK3CA in murine head and neck epithelium drives tumor invasion and metastasis through PDK1 and enhanced TGFβ signaling , 2015, Oncogene.

[65]  C. Meijer,et al.  Somatic mutation in PIK3CA is a late event in cervical carcinogenesis , 2015, The journal of pathology. Clinical research.

[66]  Raphael Kopan,et al.  The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism , 2009, Cell.

[67]  L. Liau,et al.  Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation , 2013, Nature Genetics.

[68]  Chulan Kwon,et al.  Notch Post-Translationally Regulates β-Catenin Protein in Stem and Progenitor Cells , 2011, Nature Cell Biology.

[69]  Franz Oswald,et al.  The Notch intracellular domain integrates signals from Wnt, Hedgehog, TGFβ/BMP and hypoxia pathways. , 2016, Biochimica et biophysica acta.

[70]  G. Snow,et al.  Mutated p53 as a molecular marker for the diagnosis of head and neck cancer , 2002, The Journal of pathology.

[71]  Paolo Vineis,et al.  Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[72]  Christopher R. Cabanski,et al.  Molecular Subtypes in Head and Neck Cancer Exhibit Distinct Patterns of Chromosomal Gain and Loss of Canonical Cancer Genes , 2013, PloS one.

[73]  S. Petti.  Pooled estimate of world leukoplakia prevalence: a systematic review. , 2003, Oral oncology.

[74]  M. Toner,et al.  Cytokeratin 7 in Oropharyngeal Squamous Cell Carcinoma: A Junctional Biomarker for Human Papillomavirus–Related Tumors , 2017, Cancer Epidemiology, Biomarkers & Prevention.

[75]  Wei Huang,et al.  A meta-analysis of randomized trials , 2019 .

[76]  C. Matuschek,et al.  Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[77]  Yu Shyr,et al.  Gene Expression Differences Associated with Human Papillomavirus Status in Head and Neck Squamous Cell Carcinoma , 2006, Clinical Cancer Research.

[78]  D. Rischin.  Oropharyngeal cancer, human papilloma virus, and clinical trials. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[79]  M. Yeager,et al.  HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women. , 2016, Journal of the National Cancer Institute.

[80]  Ryan K. Orosco,et al.  Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss , 2014, Nature Genetics.

[81]  K. Kinzler,et al.  Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas , 2015, Science Translational Medicine.

[82]  G. Snow,et al.  Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas , 2001, International journal of cancer.

[83]  Steven A. Roberts,et al.  Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .

[84]  Pieter Wesseling,et al.  RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics , 2015, Cancer cell.

[85]  F. Hoebers,et al.  CD44 Expression Predicts Local Recurrence after Radiotherapy in Larynx Cancer , 2010, Clinical Cancer Research.

[86]  Christopher U. Jones,et al.  Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. , 2006, The New England journal of medicine.

[87]  E. Bloemena,et al.  Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients. , 2014, Oral diseases.

[88]  J. Taube,et al.  Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy , 2016, Nature Reviews Cancer.

[89]  P J F Snijders,et al.  Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus , 2006, Oncogene.

[90]  A. McKenna,et al.  The Mutational Landscape of Head and Neck Squamous Cell Carcinoma , 2011, Science.

[91]  M. Wiesenfarth,et al.  Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16‐driven oropharyngeal squamous cell carcinoma , 2017, International journal of cancer.

[92]  R. Nusse,et al.  An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control , 2014, Science.

[93]  A. Levine,et al.  The first 30 years of p53: growing ever more complex , 2009, Nature Reviews Cancer.

[94]  K. Münger,et al.  Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming , 2011, Proceedings of the National Academy of Sciences.

[95]  Bert Vogelstein,et al.  DETECTION OF CIRCULATING TUMOR DNA IN EARLY AND LATE STAGE HUMAN MALIGNANCIES , 2014 .

[96]  B. Vogelstein,et al.  Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention , 2017, Science.

[97]  R. Addeo,et al.  Epigenetic control of gene expression: Potential implications for cancer treatment. , 2017, Critical reviews in oncology/hematology.

[98]  M. Poljak,et al.  HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients. , 2016, Journal of the National Cancer Institute.

[99]  R. Newcombe,et al.  Human papillomavirus infection is rare in nonmalignant tonsil tissue in the UK: Implications for tonsil cancer precursor lesions , 2014, International journal of cancer.

[100]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.

[101]  J. J. Lee,et al.  Loss of Heterozygosity (LOH) Profiles—Validated Risk Predictors for Progression to Oral Cancer , 2012, Cancer Prevention Research.

[102]  Q. Wei,et al.  Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers , 2013, Cancer.

[103]  M. Rietbergen,et al.  Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[104]  D. Attwell,et al.  The LIM Protein Ajuba Is Recruited to Cadherin-dependent Cell Junctions through an Association with α-Catenin* , 2003, The Journal of Biological Chemistry.

[105]  Jennifer Beane,et al.  The Case for a Pre-Cancer Genome Atlas (PCGA) , 2016, Cancer Prevention Research.

[106]  B. Graubard,et al.  Prevalence of oral HPV infection in the United States, 2009-2010. , 2012, JAMA.

[107]  G. Berx,et al.  The cell-cell adhesion molecule E-cadherin , 2008, Cellular and Molecular Life Sciences.

[108]  Shawn M. Gillespie,et al.  Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer , 2017, Cell.

[109]  K. Münger,et al.  A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer , 2012, Proceedings of the National Academy of Sciences.

[110]  Emily H Turner,et al.  Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome , 2010, Nature Genetics.

[111]  N. Normanno,et al.  Epidermal growth factor receptor (EGFR) signaling in cancer. , 2006, Gene.

[112]  M. Slijper,et al.  CD98 marks a subpopulation of head and neck squamous cell carcinoma cells with stem cell properties. , 2013, Stem cell research.

[113]  Y. Dundar,et al.  Overview of the literature , 2012 .

[114]  E. Mroz,et al.  Intra-tumor Genetic Heterogeneity and Mortality in Head and Neck Cancer: Analysis of Data from The Cancer Genome Atlas , 2015, PLoS medicine.

[115]  S. Gabriel,et al.  Systematic Review of the Literature , 2021, Adherence to Antiretroviral Therapy among Perinatal Women in Guyana.

[116]  黒滝 直弘.  私の論文から Haploinsufficiency of NSD1 causes Sotos syndrome , 2003 .

[117]  T. Akiyama,et al.  Ajuba negatively regulates the Wnt signaling pathway by promoting GSK-3β-mediated phosphorylation of β-catenin , 2008, Oncogene.

[118]  B. Vogelstein,et al.  Variation in cancer risk among tissues can be explained by the number of stem cell divisions , 2015, Science.

[119]  C. R. Leemans,et al.  Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[120]  A. Psyrri,et al.  E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. , 2009, Journal of the National Cancer Institute.

[121]  C. R. Leemans,et al.  Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. , 2004, Journal of the National Cancer Institute.

[122]  E. Giovannetti,et al.  Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets , 2017, Cancer cell.

[123]  Erica A. Golemis,et al.  Genomic insights into head and neck cancer , 2016, Cancers of the Head & Neck.

[124]  M. Pawlita,et al.  From HPV-positive towards HPV-driven oropharyngeal squamous cell carcinomas. , 2016, Cancer treatment reviews.

[125]  E. Mroz,et al.  MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma. , 2013, Oral oncology.

[126]  A L Turinsky,et al.  NSD1 mutations generate a genome-wide DNA methylation signature , 2015, Nature Communications.

[127]  R. Nusse,et al.  Wnt signaling and stem cell control , 2008, Cell Research.

[128]  C. R. Leemans,et al.  Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neck , 2017, Oncotarget.

[129]  K. Makino,et al.  Nuclear localization of EGF receptor and its potential new role as a transcription factor , 2001, Nature Cell Biology.

[130]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[131]  Benjamin F. Cravatt,et al.  Chemical Proteomics Identifies Druggable Vulnerabilities in a Genetically Defined Cancer , 2017, Cell.

[132]  K. Irvine,et al.  Ajuba Family Proteins Link JNK to Hippo Signaling , 2013, Science Signaling.

[133]  M. Rietbergen,et al.  Cancer stem cell enrichment marker CD98: a prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer. , 2014, European journal of cancer.

[134]  Allon M. Klein,et al.  Interfollicular Epidermal Stem Cells Self-Renew via Autocrine Wnt Signaling , 2013, Science.

[135]  A. Tward,et al.  High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma , 2013, Cancer.

[136]  K. Ang,et al.  Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.

[137]  R. Ferris.  Immunology and Immunotherapy of Head and Neck Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[138]  M. Rietbergen,et al.  Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm , 2013, International journal of cancer.

[139]  J. Sage,et al.  From fly wings to targeted cancer therapies: a centennial for notch signaling. , 2014, Cancer cell.

[140]  T. Akiyama,et al.  Ajuba negatively regulates the Wnt signaling pathway by promoting GSK-3beta-mediated phosphorylation of beta-catenin. , 2008, Oncogene.

[141]  M. Pawlita,et al.  Presence of DNA of Human Papillomavirus 16 but No Other Types in Tumor-Free Tonsillar Tissue , 2005, Journal of Clinical Microbiology.

[142]  M. Zahurak,et al.  Tissue Distribution of Human Papillomavirus 16 DNA Integration in Patients with Tonsillar Carcinoma , 2005, Clinical Cancer Research.

[143]  Chase W. Nelson,et al.  HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis , 2017, Cell.

[144]  Chao Lu,et al.  Retrospective study , 2016, Medicine.

[145]  S. Franceschi,et al.  Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review , 2005, Cancer Epidemiology Biomarkers & Prevention.

[146]  P. Speight,et al.  Natural history of potentially malignant oral lesions and conditions: an overview of the literature. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.